Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral ketamine for persistent somatoform pain disorder with mild to moderate depression
IRCT201508201556N80Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of ketamine in major depressive disorder (MDD) and pain disorder, sponsored by Tehran University of Medical Sciences. Started Aug 2015; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)pain disorder
Beyond the preview
Go deeper on IRCT201508201556N80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201508201556N80.